Abstract
Retinoids are effective inhibitors of chemical carcinogenesis in the skin, mammary gland, esophagus, respiratory tract, pancreas, and urinary bladder of experimental animals. Modification of the basic retinoid structure has produced retinoids with enhanced target organ specificity, resulting in increased anticancer activity with reduced systemic toxicity. Newer retinoidal benzoic acid derivatives are even more active. Combining retinoid treatment with other modulators of carcinogenesis results in a synergistic inhibition of tumor development. Retinoids in combination with hormonal manipulation are much more effective in inhibiting mammary carcinogenesis than is either treatment alone; this combination approach also inhibits mammary tumor recurrence following surgical removal of the first tumor. Retinoids are most effective when administered shortly after the carcinogenic insult. However, even when retinoid treatment is delayed, the compounds are still effective cancer chemopreventive agents for the mammary gland and urinary bladder. The time that retinoid exposure can be delayed and retain an anticancer effect is directly related to tumor latency, with a longer delay permissible against tumors with long latent periods. The mechanism(s) by which retinoids inhibit carcinogenesis is unknown; however, in the mammary gland, retinoids inhibit differentiation and proliferation, DNA synthesis, and RNA polymerase activity. Cytosolic retinoid-retinoid receptor complexing is apparently a prerequisite for the nuclear interaction of retinoids, at least in mammary cells.
We greatly appreciate the expert assistance of Patricia Moser in the preparation of this manuscript.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- TMMP:
-
trimethylmethoxyphenyl
- TPA:
-
12-O-tetradecanoyl-phorbol-13-acetate
- MNU:
-
methylnitrosourea
- OH-BBN:
-
N-butyl-N-(4-hydroxybutyl)nitrosamine
- DMBA:
-
dimethylbenz(a)anthracene
- HPR:
-
N-(4-hydroxyρhenyl)retinamide
- MVE-2:
-
a maleic anhydride-divinyl ether copolymer
References
S. D. Wolbach and P. R. Howe, Tissue changes following deprivation of fat-soluble A vitamin, J. Exp. Med. 42:753 (1925).
T. Moore, “Vitamin A,” Elsevier Publishing Corp., Amsterdam (1957).
E. Bjelke, Dietary vitamin A and human lung cancer, Int. J. Cancer 15:561 (1975).
C. Mettlin, S. Graham, and M. Swanson, Vitamin A and lung cancer, J. Natl. Cancer Inst. 62:1435 (1979).
C. Mettlin and S. Graham, Dietary risk factors in human bladder cancer, Am. J. Epidemiol. 110:255 (1979).
T. Hirayama, Diet and cancer, Nutr. Cancer 1:67 (1979).
S. Mori, The changes in the paraocular glands which follow the administration of diets low in fat-soluble A with notes of the effect of the same diets on the salivary glands and the mucosa of the larynx and trachea, Johns Hopkins Hosp. Bull. 33:357 (1922).
C. C. Harris, M. B. Sporn, D. G. Kaufman, et al., Histogenesis of squamous metaplasias in the hamster tracheal epithelium caused by vitamin A deficiency or benzo(α)pyrene ferric oxide, J. Natl. Cancer Inst. 48:743 (1972).
P. J. Becci, H. J. Thompson, C. J. Grubbs, et al., Histogenesis and dose dependence of N-methyl-N-nitrosourea-induced carcinoma in a localized area of the hamster trachea, J. Natl. Cancer Inst. 64:1135 (1980).
Y. Fujimake, Formation of carcinoma in albino rats fed on deficient diets, J. Cancer Res. 10:469 (1926).
A. E. Rogers, B. J. Herndon, and P. M. Newbeme, Induction by dimethylhydrazine of intestinal carcinoma in normal rats and rats fed high or low levels of vitamin A, Cancer Res. 33:1003 (1973).
S. M. Cohen, J. F. Wittenberg, and G. T. Bryan, Effects of avitamin-osis A and hypervitaminosis A on urinary bladder carcinogenicity of N-[4-(5-nitro-z-furyl)-2-thiazolyl]formamide, Cancer Res. 36:2334 (1976).
P. Nettesheim and M. L. Williams, The influence of vitamin A on the susceptibility of the rat lung to 3-methylcholanthrene, Int. J. Cancer 17:351 (1976).
P. M. Newbeme and A. E. Rogers, Rat colon carcinomas associated with aflatoxin and marginal vitamin A, J. Natl. Cancer Inst. 50:439 (1973).
I. Lasnitzki, Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analogs, Br. J. Cancer 34:239 (1976).
I. Lasnitzki and D. S. Goodman, Inhibition of the effects of methyl-cholanthrene on mouse prostate in organ culture by vitamin A and its analogs, Cancer Res. 34:1564 (1974).
D. P. Chopra and C. J. Wilkoff, Inhibition and reversal by β-retinoic acid of hyperplasia induced in cultured mouse prostate tissue by 3-methylcholanthrene or N-methyl-N-nitrosoquanidine, J. Natl. Cancer Inst. 56:583 (1976).
L. Harisiadis, R. C. Miller, E. J. Hall, et al., A vitamin A analogue inhibits radiation-induced oncogene transformation, Nature 274:486 (1978).
R. L. Merriman and J. S. Bertram, Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H/10T1/2 CL8 cells, Cancer Res. 39:1661 (1979).
G. J. Todaro and J. E. DeLarco, Growth factors produced by sarcoma virus transformed cells, Cancer Res. 38:4147 (1978).
G. J. Todaro, J. E. DeLarco, and M. B. Sporn, Retinoids block phenotypic cell transformation produced by sarcoma growth factor, Nature 276:272 (1978).
A. K. Verma and R. K. Boutwell, Vitamin A acid (retinoic acid) a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis, Cancer Res. 37:2196 (1977).
A. K. Verma, B. G. Shapas, H. M. Rice, et al., Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion, Cancer Res. 39:419 (1978).
M. B. Sporn and A. B. Roberts, Introduction: What is a retinoid? in: “Retinoids, Differentiation and Disease (Ciba Foundation Symposium 113),” Pittman, London (1985).
G. H. Clamon, M. B. Sporn, J. M. Smith, et al., Alpha and beta retinyl acetate reverse metaplasia of vitamin A deficiency in hamster trachea in organ culture, Nature 250:64 (1974).
C. J. Grubbs, R. C. Moon, R. A. Squire, et al., 13-cis-Retinoic acid: Inhibition of bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, Science 198:743 (1977).
P. J. Becci, H. J. Thompson, J. M. Strum, et al., N-Butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6xDBA/2F1 mice as a useful model for study of chemo-prevention of cancer with retinoids, Cancer Res. 41:927 (1981).
R. C. Moon, C. J. Grubbs, M. B. Sporn, et al., Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosourea, Nature 267:620 (1977).
A. Maiorana and P. Gullino, Effect of retinyl acetate on the incidence of mammary carcinomas and hepatomas in mice, J. Natl. Cancer Inst. 64:655 (1980).
W. Bollag and A. Matter, From vitamin A to retinoids in experimental and clinical oncology: Achievements, failures and outlook, Ann. N.Y. Acad. Sci. 359:9 (1981).
R. K. Boutwell, Diet and anticarcinogenesis in the mouse skin two stage model, Cancer Res. 43:2465s (1983).
P. Nettesheira, M. N. Cone, and C. Snyder, The influence of retinyl acetate on the post-initiation phase of preneoplastic lung nodules in rats, Cancer Res. 36:996 (1976).
C. D. Port, M. B. Sporn, and D. G. Kaufman, Prevention of lung cancer in hamsters by 13-cis-retinoic acid, Proc. Am. Assoc. Cancer Res. 16:21 (1975).
S. F. Stinson, G. Reznik, and R. Donahoe, Effect of three retinoids on tracheal carcinogenesis with N-methyl-N-nitrosourea in hamsters, J. Natl. Cancer Inst. 66:947 (1981).
C. J. Grubbs, P. J. Becci, and R. C. Moon, Characterization of 1-methyl-1-nitrosourea (MNU)-induced tracheal carcinogenesis and the effect of feeding the retinoid N-(4-hydroxyρhenyl)retinamide (4-HPR), Proc. Am. Assoc. Cancer Res. 21:102 (1980).
E. W. Chu and R. A. Malmgren, An inhibitory effect of vitamin A on the induction of tumors of forestomach and cervix in the Syrian hamster by carcinogenic hydrocarbons, Cancer Res. 25:884 (1965).
D. M. Smith, A. E. Rogers, and P. M. Newberne, Vitamin A and benzo(a)-pyrene carcinogenesis in the respiratory tract of hamsters fed a semisynthetic diet, Cancer Res. 35:1485 (1975).
R. C. Moon and L. M. Itri, Retinoids and cancer, in: “The Retinoids,” M. B. Sporn, A. B. Roberts, D. S. Goodman, eds., Academic Press, Orlando (1984).
P. M. Newberne and V. Suphakarn, Prevention role of vitamin A in colon carcinogenesis in rats, Cancer 40:2553 (1977).
J. Silverman, S. Katayama, K. Zelenakas, et al., Effect of retinoids on the induction of colon cancer in F344 rats by N-methyl-N-nitrosourea or by 1,2-dimethylhydrazine, Carcinogenesis 2:1167 (1981).
A. H. Daoud and A. C. Griffin, Effect of retinoic acid, butylated-hydroxytoluene, selenium and ascorbic acid on azo dye hepatocarcinogenesis, Cancer Lett. 9:299 (1980).
D. S. Longnecker, T. J. Curphey, E. T. Kuhlmann, et al., Inhibition of pancreatic carcinogenesis by retinoids in azaserine-treated rats, Cancer Res. 42:19 (1982).
D. F. Birt, S. Sayed, M. H. Davies, et al., Sex differences in the effects of retinoids on carcinogenesis by N-nitrosobis(2-oxoρroρyl) amine in Syrian hamsters, Cancer Lett. 14:13 (1981).
M. B. Sporn, R. A. Squire, C. C. Brown, et al., 13-cis-Retinoic acid: Inhibition of bladder carcinogenesis in the rat, Science 195:487 (1977).
R. M. Hicks, Multistage carcinogenesis in the urinary bladder, Br. Med. Bull. 36:39 (1980).
G. Murasaki, Y. Miyata, K. Babaya, et al., Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine, Gann 71:333 (1980).
D. Schmahl and M. Habs, Experiments on the influence of an aromatic retinoid on the chemical carcinogenesis in rats by butyl-butanol-nitrosamine and 1,2-dimethylhydrazine, Arzneimittelforsch. 28:49 (1978).
F. Frickel, Chemistry and physical properties of retinoids, in: “The Retinoids,” M. B. Sporn, A. B. Roberts, and D. S. Goodman, eds., Academic Press, Orlando, Fla. (1984).
R. C. Moon, R. G. Mehta, and D. L. McCormick, Retinoids and mammary gland differentiation, in: “Retinoids, Differentiation and Disease (Ciba Foundation Symposium 113),” Pittman, London (1985).
D. L. McCormick and R. C. Moon, Influence of delayed administration of retinyl acetate on mammary carcinogenesis, Cancer Res. 42:2639 (1982).
R. C. Moon and R. G. Mehta, Retinoid binding in normal and neoplastic mammary tissues, in “Hormones and Cancer,” W. W. Leavitt, ed., Plenum Press, New York (1982).
R. C. Moon, D. L. McCormick, and R. G. Mehta, Retinoid and hormone interaction in mammary carcinogenesis, in: 13th International Congress of Chemotherapy, SE 12.8.2-10 (1983).
C. W. Welsch, C. K. Brown, M. Goodrich-Smith, et al., Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats, Cancer Res. 40:3095 (1980).
J. S. Bertram, Inhibition of neoplastic transformation in vitro by retinoids, Cancer Surveys 3:243 (1983).
H. J. Thompson, L. D. Meeker, and P. J. Becci, Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis, Cancer Res. 41:1413 (1981).
C. Ip and M. M. Ip, Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A, Carcinogenesis 2:915 (1981).
D. L. McCormick, P. J. Becci, and R. C. Moon, Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2), Carcinogenesis 3:1473 (1982).
A. B. Roberts and M. B. Sporn, Cellular biology and biochemistry of the retinoids, in “The Retinoids,” M. B. Sporn, A. B. Roberts, and D. S. Goodman, eds., Academic Press, Orlando (1984).
R. C. Moon, H. J. Thompson, P. J. Becci, et al., N-(4-Hydroxyρhenyl) retinamide, a new retinoid for prevention of breast cancer in the rat, Cancer Res. 39:1339 (1979).
R. G. Mehta and R. C. Moon, Inhibition of DNA synthesis by retinyl acetate during chemically induced mammary carcinogenesis, Cancer Res. 40:1109 (1981).
D. L. McCormick, F. J. Burns, and R. E. Albert, Inhibition of benzo(α) pyrene-induced mammary carcinogenesis by retinyl acetate, J. Natl. Cancer Inst. 66:559 (1981).
R. G. Mehta, W. L. Cerny, and R. C. Moon, Retinoid inhibition of prolactin-induced development of the mammary gland in vitro, Carcinogenesis 4:23 (1983).
R. C. Moon, D. L. McCormick, and R. G. Mehta, Inhibition of carcinogenesis by retinoids, Cancer Res. 43:2469s (1983).
R. C. Moon, C. J. Grubbs, and M. B. Sporn, Inhibition of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis by retinyl acetate, Cancer Res. 36:2626 (1976).
R. G. Mehta and R. C. Moon, Hormonal regulation of retinoic acid-binding proteins in the mammary gland, Biochem. J. 200:591 (1981).
R. G. Mehta, W. L. Cerny, and R. C. Moon, Distribution of retinoic acid-binding protein in normal and neoplastic mammary tissues, Cancer Res. 40:47 (1980).
R. G. Mehta, T. E. Kute, M. Hopkins, et al., Retinoic acid-binding proteins and steroid receptor levels in human breast cancer, Eur. J. Cancer Clin. Oncol. 18:221 (1982).
T. A. Hultin and R. C. Moon, Metabolism of N-(4-hydroxyphenyl)retinamide in female rats and mice, Fed. Proc. 44:1338 (1985).
R. G. Mehta, W. L. Cerny, and R. C. Moon, Nuclear interaction of retinoic acid binding protein in chemically induced mammary adenocarcinomas, Biochem. J. 208:731 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Moon, R.C., Mehta, R.G. (1986). Anticarcinogenic Effects of Retinoids in Animals. In: Poirier, L.A., Newberne, P.M., Pariza, M.W. (eds) Essential Nutrients in Carcinogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1835-4_29
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1835-4_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9025-4
Online ISBN: 978-1-4613-1835-4
eBook Packages: Springer Book Archive